Table 3.
Antibiotic susceptibility patterns of E. coli isolates.
| Antibiotic | R% n |
I% n |
S% n |
|---|---|---|---|
| Amoxicillin | (70.8)17 | 0 | (29.2)7 |
| Ampicillin | (70.8)17 | 0 | (29.2) 7 |
| Amoxicillin/clavulanic Acid | (16.7)4 | (16.7) 4 | (66.7) 16 |
| Amoxicillin/Sulbactam | (12.5) 3 | 0 | (87.5) 21 |
| Piperacillin/Tazobactam | (12.5) 3 | (12.5) 3 | (75) 18 |
| Cefalotin | (33.3) 8 | (12.5) 3 | (54.2) 13 |
| Cefuroxime | (29.2) 7 | 0 | (70.8)17 |
| Cefoxitin | (12.5) 3 | (4.2) 1 | (83.3) 20 |
| Cefixime | (29.2) 7 | 0 | (70.8)17 |
| Cefotaxime | (20.3) 5 | 0 | (79.2) 19 |
| Ceftazidime | (16.7) 4 | (4.2) 1 | (79.2) 19 |
| Ceftriaxone | (20.3) 5 | 0 | (79.2) 19 |
| Cefepime | (16.7) 4 | 0 | (83.3) 20 |
| Aztreonam | (16.7) 4 | 0 | (83.3) 20 |
| Imipenem | 0 | 0 | (100) 24 |
| Meropenem | 0 | 0 | (100) 24 |
| Amikacin | 0 | (4.2) 1 | (95.8) 23 |
| Gentamicin | (8.3) 2 | 0 | (91.7) 22 |
| Ciprofloxacin | (41.7) 10 | 0 | (58.3) 14 |
| Norfloxacin | (66.7) 16 | – | – |
| Ofloxacin | (41.7)10 | 0 | (58.3) 14 |
| Doxycyclin | – | – | – |
| Minocycline | – | – | – |
| Tigecycline | 0 | 0 | (100) 24 |
| Nitrofurantoin | (4.2) 1 | (12.5) 3 | (83.3) 20 |
| Trimethoprim/Sulfamethoxazole | (50) 12 | 0 | (50) 12 |
R: Resistant, I: Intermediate, S: Susceptible.